多系统畸形胎儿的全外显子组测序诊断率:系统综述与Meta分析
该系统综述纳入17篇文献共694例多系统畸形胎儿,在染色体微阵列分析或核型分析阴性后行全外显子组测序,额外诊断率为33%(95%CI 27-40%)。亚组分析显示,单人测序策略诊断率为30%(95%CI 11-52%),三人测序策略为35%(95%CI 26-44%),两者相似。
要点
- 多系统畸形胎儿在CMA或核型分析阴性后,ES额外诊断率为33%(95%CI 27-40%)。
- 涉及至少两个不同解剖系统主要畸形的胎儿,ES可检出约三分之一潜在致病基因变异。
- 单人测序(30%)与三人测序(35%)诊断率相似,95%CI均较宽且重叠。
核心结论
- 在多系统结构畸形胎儿中,当CMA或核型分析未检出病因时,ES可额外在约三分之一病例中检出潜在致病基因;单人测序与三人测序策略之间未见差异。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、Web of Knowledge和Cochrane数据库,纳入17篇观察性研究共694例多系统畸形胎儿,以CMA或核型分析阴性为参考标准,采用随机效应模型进行单比例分析计算诊断率。
诊断标准与关键数值
- 诊断率定义为检出可能致病或致病且判定为导致胎儿表型的变异;总体ES额外诊断率33%(95%CI 27-40%),单人测序30%(95%CI 11-52%),三人测序35%(95%CI 26-44%)。
临床应用与阅片要点
- 对多系统畸形胎儿,在CMA或核型分析阴性后,可考虑全外显子组测序以检出潜在致病基因变异;单人测序与三人测序策略诊断率未见差异。
局限性
- 单人测序策略诊断率的95%CI较宽(11-52%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the diagnostic yield of exome sequencing (ES) above that of chromosomal microarray analysis (CMA) or karyotyping in fetuses with multisystem structural anomalies (at least two major anomalies in different anatomical systems).
METHOD: This was a systematic review conducted in accordance with PRISMA guidelines. Searching PubMed, Web of Knowledge and Cochrane database, we identified studies describing ES, whole-genome and/or next-generation sequencing in fetuses with multisystem malformations. Included were observational studies involving five or more eligible fetuses. A fetus was eligible for inclusion if it had at least two major anomalies of different anatomical systems and a negative CMA or karyotyping result. Only positive variants classified as likely pathogenic or pathogenic determined to be causative of the fetal phenotype were considered. A negative CMA or karyotype result was treated as the reference standard. The diagnostic yield of the primary outcome was calculated by single-proportion analysis using random-effects modeling. A subgroup analysis was performed to compare the diagnostic yield of the solo approach (fetus alone sequenced) with that of the trio approach (fetus and both parents sequenced).
RESULTS: Seventeen articles with data on ES diagnostic yield, including 694 individuals with multisystem malformations, were identified. Overall, a pathogenic or likely pathogenic variant potentially causative of the fetal phenotype was found in 213 fetuses, giving a 33% (95% CI, 27-40%) incremental yield of ES. A stratified analysis showed similar diagnostic yields of ES using the solo approach (30%; 95% CI, 11-52%) and the trio approach (35%; 95% CI, 26-44%).
CONCLUSIONS: ES applied in fetuses with multisystem structural anomalies was able to identify a potentially causative gene when CMA or karyotyping had failed to do so in an additional one-third of cases. No differences were observed between the solo and trio approaches for ES. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Pauta M, Martinez-Portilla RJ, Borrell A, et al. Diagnostic yield of exome sequencing in fetuses with multisystem malformations: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 35041238. doi:10.1002/uog.24862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。